Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $40.4500 (1.13%) ($39.7500 - $41.2300) on Thu. Aug. 30, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 59 | Latest Price | $40.4500(1.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.645% in a week (0% probabilities). VXX(-14%) VIXM(-14%) TLT(-14%) UUP(-12%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | 0 () | Intraday Trend | 1% | | | |
|
5 Day Moving Average | $39.65(2.02%) | 10 Day Moving Average | $38.43(5.26%) | 20 Day Moving Average | $37.81(6.98%) | To recent high | -19% | To recent low | 15.4% | Market Cap | $3.006b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |